Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant
fitness cost
fosfomycin
linezolid
resistance
virulence
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
06
2022
accepted:
20
08
2022
entrez:
6
9
2022
pubmed:
7
9
2022
medline:
7
9
2022
Statut:
epublish
Résumé
We aimed to evaluate the synergistic effect of linezolid and fosfomycin on fosfomycin-sensitive and -resistant The synergistic effect of linezolid and fosfomycin was studied via in vitro checkerboard and static time-kill assays, as well as based on the in vivo survival rate and hemolymph load of a In vitro and in vivo data showed that linezolid combined with fosfomycin had a good synergistic effect on Linezolid combined with fosfomycin had a synergistic effect on both fosfomycin-sensitive and -resistant
Identifiants
pubmed: 36065277
doi: 10.2147/IDR.S377848
pii: 377848
pmc: PMC9440711
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4995-5010Informations de copyright
© 2022 Li et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Antibiotics (Basel). 2021 Feb 22;10(2):
pubmed: 33671753
Antibiotics (Basel). 2021 Sep 27;10(10):
pubmed: 34680753
Crit Care Med. 2018 Oct;46(10):1634-1642
pubmed: 29957707
Infect Drug Resist. 2018 Aug 08;11:1105-1117
pubmed: 30127628
Virulence. 2018 Dec 31;9(1):860-865
pubmed: 29726300
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115241
pubmed: 33130503
Clin Microbiol Rev. 2019 Jan 30;32(2):
pubmed: 30700430
J Antimicrob Chemother. 2020 Aug 1;75(8):2173-2181
pubmed: 32357212
Antimicrob Agents Chemother. 2007 Apr;51(4):1287-92
pubmed: 17242144
J Antimicrob Chemother. 2012 Jun;67(6):1325-32
pubmed: 22378682
Antibiotics (Basel). 2021 Jul 19;10(7):
pubmed: 34356793
Helicobacter. 2021 Aug;26(4):e12808
pubmed: 33884706
Nat Med. 2006 May;12(5):515-7
pubmed: 16633349
Infect Drug Resist. 2021 Feb 24;14:639-649
pubmed: 33658805
J Antimicrob Chemother. 2018 Mar 1;73(3):709-719
pubmed: 29253153
PLoS Genet. 2018 Sep 4;14(9):e1007525
pubmed: 30180166
Int J Antimicrob Agents. 2020 Jul;56(1):105935
pubmed: 32156620
Nat Rev Microbiol. 2019 Jan;17(2):82-94
pubmed: 30337708
J Am Coll Cardiol. 2019 Nov 12;74(19):2435-2436
pubmed: 31699288
Front Microbiol. 2019 Aug 28;10:2001
pubmed: 31555237
Infect Drug Resist. 2019 Nov 12;12:3497-3505
pubmed: 31814738
Nat Microbiol. 2021 Jan;6(1):103-111
pubmed: 33106672
Evol Appl. 2015 Mar;8(3):273-83
pubmed: 25861385
Front Cell Infect Microbiol. 2021 Dec 22;11:782733
pubmed: 35004350
Pharmaceutics. 2021 Aug 31;13(9):
pubmed: 34575453
BMC Complement Altern Med. 2018 May 30;18(1):169
pubmed: 29848316
Biomed Res Int. 2016;2016:6413982
pubmed: 27366751
J Hosp Infect. 2018 Jul;99(3):346-355
pubmed: 29066140
Antibiotics (Basel). 2022 Mar 24;11(4):
pubmed: 35453188
Eur J Clin Pharmacol. 2022 Aug;78(8):1301-1310
pubmed: 35610318
mSphere. 2019 Feb 13;4(1):
pubmed: 30760612
Int J Med Microbiol. 2021 Feb;311(2):151477
pubmed: 33524636
Front Pharmacol. 2022 Jan 28;12:773994
pubmed: 35153743
Tuberculosis (Edinb). 2021 Jul;129:102091
pubmed: 34090078
J Glob Antimicrob Resist. 2020 Sep;22:78-83
pubmed: 32007618
Genome Biol. 2018 Jul 18;19(1):94
pubmed: 30021593
Front Microbiol. 2021 Dec 14;12:779885
pubmed: 34970238
J Antimicrob Chemother. 2020 Jul 1;75(7):1704-1711
pubmed: 32129849
Inflammation. 2021 Dec;44(6):2429-2447
pubmed: 34505975
J Antibiot (Tokyo). 2017 Feb;70(2):166-173
pubmed: 27756910
Pathogens. 2021 Nov 14;10(11):
pubmed: 34832638
Expert Rev Anti Infect Ther. 2022 Jan;20(1):33-43
pubmed: 34030567
Ann Transl Med. 2022 Feb;10(3):148
pubmed: 35284561
Diagn Microbiol Infect Dis. 2018 Jun;91(2):161-163
pubmed: 29496381
BMC Microbiol. 2020 Jun 15;20(1):162
pubmed: 32539684
Pharmacotherapy. 2019 Nov;39(11):1077-1094
pubmed: 31487056
Front Microbiol. 2021 Feb 09;11:605962
pubmed: 33633692
Nat Microbiol. 2021 Nov;6(11):1410-1423
pubmed: 34697460
Nat Rev Microbiol. 2017 Jul;15(7):382-383
pubmed: 28579609
Int J Antimicrob Agents. 2019 Jan;53(1):22-28
pubmed: 30268576
Antibiotics (Basel). 2021 Dec 17;10(12):
pubmed: 34943757
Pathol Biol (Paris). 2012 Apr;60(2):e9-14
pubmed: 19942376
Clin Infect Dis. 2004 Jan 1;38(1):155-6
pubmed: 14679466
Front Vet Sci. 2022 Feb 11;9:801800
pubmed: 35224081
Infect Drug Resist. 2019 Jul 11;12:2049-2057
pubmed: 31372012
Int J Med Microbiol. 2017 Dec;307(8):452-459
pubmed: 28986014
Emerg Infect Dis. 2017 Nov;23(11):1902-1904
pubmed: 29048285
J Microbiol Immunol Infect. 2017 Feb;50(1):55-61
pubmed: 25682237
Expert Opin Investig Drugs. 2009 Jul;18(7):921-44
pubmed: 19548851
Front Med (Lausanne). 2021 Sep 10;8:720647
pubmed: 34568377
J Antimicrob Chemother. 2007 Jan;59(1):28-34
pubmed: 17065188
Microbiol Spectr. 2021 Dec 22;9(3):e0087121
pubmed: 34851157
Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1441-1448
pubmed: 29909468
BMC Genomics. 2019 Oct 22;20(1):761
pubmed: 31640552
J Microbiol Immunol Infect. 2020 Oct;53(5):731-738
pubmed: 30638785
Sci Rep. 2016 Jan 18;6:19262
pubmed: 26778774
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9274-9281
pubmed: 33015768
mBio. 2020 Feb 11;11(1):
pubmed: 32047136
Front Microbiol. 2014 Nov 10;5:544
pubmed: 25426104
J Fungi (Basel). 2021 Nov 26;7(12):
pubmed: 34946994
Clin Infect Dis. 2015 Oct 15;61Suppl 3:S147-54
pubmed: 26409276
mBio. 2017 Feb 21;8(1):
pubmed: 28223450